U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06803082) titled 'The Impact of Systemic Light Chain Amyloidosis on Eyes' on Dec. 13, 2024.
Brief Summary: Study Purpose and Principle: Amyloidosis is a group of diseases characterized by the deposition of amyloid proteins in tissues and organs throughout the body, with common affected organs including kidneys, heart, nervous system, gastrointestinal tract, and liver. Nowadays, nearly 40 different proteins have been found to form amyloid fibrils in body, among which Systemic Light Chain (AL) Amyloidosis is the most common type of systemic amyloidosis. AL amyloidosis is a plasma cell disorder, with its precursor protein originating from free light chai...